Results 61 to 70 of about 50,613 (304)
Background: Psoriasis is a chronic inflammatory disease involving the skin and/or joints. Till 2016, there were five biologic agents for psoriatic arthritis treatment in Taiwan: etanercept, adalimumab, golimumab, ustekinumab, and secukinumab.
Sebastian Yu +3 more
doaj +1 more source
Caracterització de la sinovitis mitjançant mètodes artroscòpics i immunohistoquímics. Valor diagnòstic i pronòstic [PDF]
[cat] La membrana sinovial, és el lloc on s'inicia i es perpetua el procés inflamatori que caracteritza a les diferents artropaties inflamatòries. A diferència d'altres òrgans no té una estructura definida, motiu pel qual el context on es produeix la ...
Salvador Alarcón, Georgina
core
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang +10 more
wiley +1 more source
Objective This study aimed to describe real‐world trends in preconception and prenatal use of antirheumatic drugs among pregnant individuals with rheumatic diseases in Ontario, Canada. Methods We conducted a time‐series analysis using repeated cross‐sectional data to examine annual patterns of disease‐modifying antirheumatic drug (DMARD) use among ...
Shenthuraan Tharmarajah +6 more
wiley +1 more source
Understanding the transition from psoriasis to psoriatic arthritis: the role of targeted therapy
: Most individuals who develop psoriatic arthritis (PsA) first present with psoriasis (PsC), often years before musculoskeletal symptoms emerge. Progression from PsC to PsA is multifactorial, shaped by genetic and environmental influences, and may ...
Fadi Kharouf +4 more
doaj +1 more source
Background Previous research to describe the impact of foot involvement in psoriatic arthritis has used the Leeds Foot Impact Scale in Rheumatoid Arthritis (LFIS-RA) in the current absence of any psoriatic arthritis foot-specific tools. However, the LFIS-
Kate Carter +4 more
doaj +1 more source
Challenges of biological therapy in patients with pustular psoriasis coexisting with psoriatic arthritis [PDF]
Introduction . Psoriasis is a chronic inflammatory skin disease affecting approximately 2–3% of the general population. It is a condition with immunological and genetic background, coexisting with psoriatic arthritis in about 25% of cases. Biologic drugs
Joanna Narbutt +4 more
core +1 more source
Objective This study aims to investigate lifestyle‐related factors in patients with psoriatic arthritis (PsA) and their association with disease activity measurements. Methods This multicenter cohort included 938 patients who were newly diagnosed with PsA between 2013 and 2023.
Batoul Hojeij +11 more
wiley +1 more source
AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
Psoriatic arthritis is a chronic progressive systemic inflammatory disease of joints and spine, which leads to the development of erosive arthritis, bone resorbtion, multiple enthesitis and spondylitis. Severe clinical course, resistance to therapy, high
A. A. Barilo +2 more
doaj +1 more source
We demonstrated that high humidity worsened psoriasis relapse in murine psoriasiform skin inflammation by increasing skin‐resident memory CD8+ cells via upregulating IL‐15Rα on keratinocytes. The increases in IL‐15Rα and memory CD8+ cells were attributed to S. nepalensis and its metabolite ADMA in skin exposed to high humidity.
Chun‐Ling Liang +10 more
wiley +1 more source

